I am a
Home I AM A Search Login

Papers of the Week

2022 Oct 01

Eur J Endocrinol

Levoketoconazole treatment in endogenous Cushing’s syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes.


Fleseriu M, Auchus RJ, Greenman Y, Zacharieva S, Geer EB, Salvatori R, Pivonello R, Feldt-Rasmussen U, Kennedy L, Buchfelder M, Biller BMK, Cohen F, Heaney AP
Eur J Endocrinol. 2022 Oct 01.
PMID: 36251618.


This extended evaluation (EE) of the SONICS study assessed effects of levoketoconazole for an additional 6 months following open-label, 6-month maintenance treatment in endogenous Cushing's syndrome.